CEC 15th Anniversary | Professor Guo Wei: 15-Year Progress and Future Prospects of Aortic Aneurysm

Dear esteemed experts and colleagues：Hello, everyone!

Over the past 15 years, with the relentless advancement of medical technology, endovascular treatment for aortic aneurysms has achieved remarkable progress and widespread implementation, yielding numerous significant research outcomes. Yet, this progress has also surfaced numerous new challenges.

In this keynote lecture, we will briefly review the early explorations of endovascular treatment for aortic aneurysms, the clinical issues it has addressed, and delve deeper into the crux of contemporary technology. This includes the recent advancements and clinical evidence surrounding the reconstruction of the aortic root, aortic arch branches, visceral artery branches, and iliac artery branches. Additionally, we will present the outcomes of non-implant interventional techniques for small and medium-sized aneurysms and offer an outlook for the future of aortic aneurysm treatment.

Firstly, our focus will be on the advancements in endovascular repair of the ascending aorta based on coronary artery reconstruction. With the emergence of techniques such as Endo-Bentall, patients with Type A aortic dissection, traditionally requiring open surgery, now have a novel endovascular treatment option. We will discuss the principles, operational procedures, anatomical prerequisites, and current limitations of these techniques, sharing preliminary applications and clinical outcomes in emergency settings.

Secondly, we will concentrate on aneurysms involving the aortic arch, visceral arteries, and iliac artery branches. Centering on endovascular repair and multi-branch reconstruction, we will introduce the progress of new devices and technological trends both domestically and internationally. As clinical evidence accumulates and new devices emerge, the "Chinese Solution" for these complex aortic aneurysm endovascular treatments will establish a new system and set of rules tailored to the characteristics of the domestic population, offering patients more individualized treatment plans that align with their anatomical features, with aspirations to extend our reach globally.

Lastly, we will explore the therapeutic advancements for small and medium-sized aneurysms. For patients who do not meet surgical indications, we will present clinical evidence on drug inhibition of aortic aneurysm progression, discuss the selection of drug carriers, geometric designs, and fluid dynamics during drug delivery, positioning pharmacotherapy as an emerging frontier in the future treatment of aortic aneurysms.

We cordially invite you to participate in the "CEC-15th Anniversary Special Edition" Academic Forum and the 2023 Annual Academic Meeting of the Vascular Surgery Branch of the Cross-Strait Medical and Health Exchange Association, to be held online from November 3 to 4, 2023. We eagerly anticipate engaging with you in discussions about the latest advancements and future prospects of endovascular treatment for aortic aneurysms. Through sharing experiences and exchanging ideas, we are confident that we can enhance patient care and propel the development of vascular medicine.